Other studies have also shown that Hsp90 plays an important role in regulating the stability of PTK6, raising the possibility that Hsp90 inhibitors may be used as therapeutic drugs for PTK6-positive cancers,including breast cancer [54]. Here, PTK6 is linked to cancer.